Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Baxalta raises $5B in notes offering ahead of spinout

    The Baxalta Inc. subsidiary of Baxter International Inc. (NYSE:BAX) raised $5 billion in a senior notes offering. The offering includes $375 million in 2% notes due 2018, $1 billion in 2.875% notes due 2020, $500 …

    Published on 6/19/2015
  • FINANCIAL NEWS: Celyad shares fall after U.S. listing

    Celyad S.A. (NASDAQ:CYAD; Euronext:CYAD) dropped $13.99 (20%) to $54.57 in its first day of trading on NASDAQ Friday after it raised $100.1 million through the sale of ADSs and a private placement of ordinary shares. …

    Published on 6/19/2015
  • FINANCIAL NEWS: Cure Forward raises $15M in series A round

    Cure Forward (Cambridge, Mass.) raised $15 million in a series A round. Apple Tree Partners was the sole investor. The company expects to launch a technology platform in September that is designed to connect cancer …

    Published on 6/19/2015
  • FINANCIAL NEWS: Financial tracks

    Credit Suisse hired Robert Glassman as vice chairman of global heathcare investment banking. He was managing director of healthcare investment banking at Bank of America.

    Published on 6/19/2015
  • FINANCIAL NEWS: PureTech raises L108.2M in London IPO

    PureTech Health plc (LSE:PRTC) raised L108.2 million ($168 million) through the sale of 67.6 million shares at 160p in an IPO underwritten by Jefferies and Peel Hunt. The price values the company at L363.6 million ($564…

    Published on 6/19/2015
  • FINANCIAL NEWS: Advanced Cell Diagnostics raises $22M in series C

    Advanced Cell Diagnostics Inc. (Hayward, Calif.) raised $22 million in a series C round led by Summit Partners. Kenson Ventures and existing investors Morningside Ventures and New Leaf Venture Partners also participated…

    Published on 6/18/2015
  • FINANCIAL NEWS: Cynapsus raises $63M in U.S. listing

    Cynapsus Therapeutics Inc. (TSX:CTH; NASDAQ:CYNA) gained $0.64 to $14.64 in its first day of trading Thursday on NASDAQ after it raised $63 million through the sale of 4.5 million shares at $14 in an offering …

    Published on 6/18/2015
  • FINANCIAL NEWS: Organovo raises $40.1M in follow-on

    Organovo Holdings Inc. (NYSE-M:ONVO) raised $40.1 million through the sale of 9.4 million shares at $4.25 in a follow-on underwritten by Jefferies; Piper Jaffray; and Cantor Fitzgerald. The company proposed the offering…

    Published on 6/18/2015
  • FINANCIAL NEWS: Cynvenio raises $25.5 million in series B

    Cynvenio Biosystems Inc. (Westlake Village, Calif.) raised $25.5 million in a series B round led by Livzon Pharmaceutical Group Inc. (SZSE:000513; HKSE:1513). Greenwoods Private Equity Funds and Syno Capital also …

    Published on 6/17/2015
  • FINANCIAL NEWS: CytomX raises $70M in series D

    CytomX Therapeutics Inc. (South San Francisco, Calif.) raised $70 million in a series D round led by Fidelity Management and Research Co. Also participating were Casdin Capital; Cormorant Asset Management; Deerfield …

    Published on 6/17/2015
  • FINANCIAL NEWS: Nivalis gains after upsized $77M IPO

    Nivalis Therapeutics Inc. (NASDAQ:NVLS) gained $0.92 to $14.92 in its first day of trading after raising $77 million through the sale of 5.5 million shares at $14 in a bumped-up IPO underwritten by Cowen; Stifel; Baird;…

    Published on 6/17/2015
  • FINANCIAL NEWS: Onyx spinout Kezar raises $23M in series A

    Kezar Life Sciences (South San Francisco, Calif.), a newco that houses assets spun out from the Onyx Pharmaceuticals Inc. subsidiary of Amgen Inc. (NASDAQ:AMGN), raised $23 million in a series A round. Investors …

    Published on 6/16/2015
  • FINANCIAL NEWS: Pulmatrix finds public path via Ruthigen merger

    Pulmatrix Inc. (NASDAQ:PULM) lost $0.85 to $11.80 in its first day of trading after it completed a reverse merger with Ruthigen Inc. and raised $10 million in a private placement with new investor Altitude Life Science …

    Published on 6/16/2015
  • FINANCIAL NEWS: Avalon, GSK launch three more biotechs

    Avalon Ventures and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) launched three build-to-buy companies, each with $3 million in series A funding and $7 million in R&D support.Adrenergics Inc. is focused on therapies for …

    Published on 6/15/2015
  • FINANCIAL NEWS: Amicus raises $225M in follow-on

    Orphan disease company Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $225 million through the sale of 17 million shares at $13.25 in a follow-on underwritten by JPMorgan; Goldman Sachs; Cowen; and Janney Montgomery …

    Published on 6/12/2015
  • FINANCIAL NEWS: Biotie raises $92.9M in listing, note deal

    Biotie Therapies Corp. (HSE:BTH1V; NASDAQ:BITI) gained $5.73 (39%) to $20.61 in its first day of trading on NASDAQ after raising $92.9 million via a listing of ADSs and a concurrent note deal. The company raised $56 …

    Published on 6/11/2015
  • FINANCIAL NEWS: Chinese investor group backs BioAtla in $30M round

    BioAtla LLC (San Diego, Calif.) raised $30 million in equity funding from an undisclosed investor group based in China.The company is developing early stage Conditionally Active Biologics (CABs) that are activated in …

    Published on 6/11/2015
  • FINANCIAL NEWS: Follow-on round-up: Chimerix, Ignyta

    Chimerix Inc. (NASDAQ:CMRX) and Ignyta Inc. (NASDAQ:RXDX) raised a combined $225.1 million in follow-ons. Antivirals developer Chimerix raised $150.1 million through the sale of 3.8 million shares at $39.75. Morgan …

    Published on 6/11/2015
  • FINANCIAL NEWS: Unum raises $65 million in series B

    Unum Therapeutics Inc. (Cambridge, Mass.) raised $65 million in a series B round led by new investor New Leaf Venture Partners. New investors Brace Pharma Capital; Cowen Private Investments; Jennison Associates; Novo A/…

    Published on 6/11/2015
  • FINANCIAL NEWS: XTuit raises $22 million in series A

    XTuit Pharmaceuticals Inc. (Cambridge, Mass.) raised $22 million in a series A round led by New Enterprise Associates. New investors CTI Life Sciences, Arcus Ventures and Omega Funds also participated, as did founding …

    Published on 6/11/2015
  • FINANCIAL NEWS: 3SBio raises HK$4.4B in Hong Kong IPO

    3SBio Inc. (HKSE:1530) raised HK$4.4 billion ($569.2 million) through the sale of 484.9 million shares at HK$9.10 in an IPO on the Hong Kong Stock Exchange. The price values the company at HK$22.1 billion ($2.8 billion…

    Published on 6/10/2015
  • FINANCIAL NEWS: Heron, China Biologic price follow-ons

    Heron Therapeutics Inc. (NASDAQ:HRTX) and China Biologic Products Inc. (NASDAQ:CBPO) raised a total of $192.3 million in follow-ons on Wednesday.Drug delivery company Heron raised $118.8 million through the sale of 4.8 …

    Published on 6/10/2015
  • FINANCIAL NEWS: Ironwood raises $300M in note deal

    Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) raised $300 million through the sale of convertible senior unsecured notes. The notes bear 2.25% interest, mature on June 15, 2022, and convert initially at $16.58 per share. …

    Published on 6/10/2015
  • FINANCIAL NEWS: Melinta raises $46M toward venture round

    Melinta Therapeutics Inc. (New Haven, Conn.) raised $46 million of a planned $67 million venture round led by new investor Malin Corp. plc (ISE:MLC). Existing investor Vatera Healthcare Partners and additional …

    Published on 6/10/2015
  • FINANCIAL NEWS: Circassia raises L275M to fund pair of acquisitions

    Allergy company Circassia Pharmaceuticals plc (LSE:CIR) raised L275 million ($420.1 million) through the sale of 95.5 million shares at L2.88 in a placing and open offer underwritten by JPMorgan Cazenove and Peel Hunt. …

    Published on 6/9/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993